Full-field stimulus testing (FST) to quantify visual perception in severely blind candidates for treatment trials
- PMID: 17664667
- DOI: 10.1088/0967-3334/28/8/N02
Full-field stimulus testing (FST) to quantify visual perception in severely blind candidates for treatment trials
Abstract
Incurable genetic retinal blindness is in readiness for clinical trials to attempt restoration of vision. Early trials will involve those patients with the most severe visual losses, but there are no standard methods to quantify extremely abnormal visual perception. Full-field stimulus testing (FST) has been devised to fill this need. The current work advances FST to assay vision in the most severely blind patients using achromatic and chromatic stimuli in an LED-based visual stimulator. Our studies of this new FST in a cohort of retinal degeneration patients show the feasibility of the technique in a clinical setting. Results and variability of the new FST were comparable to our earlier FST device when vision was measurable with both. The extension of the dynamic range of chromatic and achromatic stimuli in the new FST by 2 log units allowed vision that was previously not measurable to be quantified. With this advance, inclusion and exclusion criteria can be developed and safety as well as efficacy outcomes measured in upcoming treatment trials of severe retinal blindness.
Similar articles
-
Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures.Exp Eye Res. 2005 Feb;80(2):259-72. doi: 10.1016/j.exer.2004.09.008. Exp Eye Res. 2005. PMID: 15670804
-
Artificial vision: needs, functioning, and testing of a retinal electronic prosthesis.Prog Brain Res. 2009;175:317-32. doi: 10.1016/S0079-6123(09)17522-2. Prog Brain Res. 2009. PMID: 19660665 Review.
-
Psychophysical assessment of low visual function in patients with retinal degenerative diseases (RDDs) with the Diagnosys full-field stimulus threshold (D-FST).Doc Ophthalmol. 2009 Dec;119(3):217-24. doi: 10.1007/s10633-009-9204-7. Epub 2009 Nov 3. Doc Ophthalmol. 2009. PMID: 19885692 Free PMC article.
-
Visual field changes after a rehabilitation intervention: vision restoration therapy.J Neurol Sci. 2008 Oct 15;273(1-2):70-4. doi: 10.1016/j.jns.2008.06.026. Epub 2008 Jul 30. J Neurol Sci. 2008. PMID: 18672255 Clinical Trial.
-
Alström syndrome--a case report and literature review.Klin Oczna. 2008;110(4-6):188-92. Klin Oczna. 2008. PMID: 18655459 Review.
Cited by
-
Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years.Arch Ophthalmol. 2012 Jan;130(1):9-24. doi: 10.1001/archophthalmol.2011.298. Epub 2011 Sep 12. Arch Ophthalmol. 2012. PMID: 21911650 Free PMC article. Clinical Trial.
-
The RUSH2A Study: Best-Corrected Visual Acuity, Full-Field Electroretinography Amplitudes, and Full-Field Stimulus Thresholds at Baseline.Transl Vis Sci Technol. 2020 Oct 8;9(11):9. doi: 10.1167/tvst.9.11.9. eCollection 2020 Oct. Transl Vis Sci Technol. 2020. PMID: 33133772 Free PMC article.
-
Safety and improved efficacy signals following gene therapy in childhood blindness caused by GUCY2D mutations.iScience. 2021 Apr 11;24(5):102409. doi: 10.1016/j.isci.2021.102409. eCollection 2021 May 21. iScience. 2021. PMID: 33997691 Free PMC article.
-
Night vision restored in days after decades of congenital blindness.iScience. 2022 Oct 4;25(10):105274. doi: 10.1016/j.isci.2022.105274. eCollection 2022 Oct 21. iScience. 2022. PMID: 36274938 Free PMC article.
-
Evaluation of Full-Field Stimulus Threshold Test Results in Retinitis Pigmentosa: Relationship with Full-Field Electroretinography, Multifocal Electroretinography, Optical Coherence Tomography, and Visual Field.Turk J Ophthalmol. 2024 Feb 22;54(1):23-31. doi: 10.4274/tjo.galenos.2023.58485. Turk J Ophthalmol. 2024. PMID: 38385317 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
